TipRanks
Tue, November 11, 2025 astatine 5:55 AM CST 1 min read
Canaccord lowered the firm’s price target connected Zimmer Biomet (ZBH) to $93 from $101 and keeps a Hold standing connected the shares. The steadfast updated its exemplary pursuing Q3 results and consequent 10Q release. They noted the institution tightened its guidance and reiterated reported maturation of 6.7-7.7% with the FNA acquisition expected to lend astir 270bps to growth.
-
Discover however TipRanks' ETF AI Analyst tin assistance you marque smarter concern decisions
-
Explore ETFs TipRanks' users emotion and spot what insights the ETF AI Analyst reveals astir the ones you follow.
Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>
See the apical stocks recommended by analysts >>
Read More connected ZBH:
Disclaimer & DisclosureReport an Issue
-
Zimmer Biomet terms people lowered to $88 from $96 astatine UBS
-
Zimmer Biomet terms people lowered to $117 from $125 astatine Baird
-
Zimmer Biomet Reports Strong Q3 2025 Earnings
-
Zimmer Biomet terms people lowered to $97 from $106 astatine Goldman Sachs
-
Zimmer Biomet’s Earnings Call: Growth Amid Challenges

6 days ago
6






English (CA) ·
English (US) ·
Spanish (MX) ·